Addus HomeCare's (ADUS) "Market Outperform" Rating Reaffirmed at JMP Securities

JMP Securities reissued their market outperform rating on shares of Addus HomeCare (NASDAQ:ADUS - Free Report) in a research report report published on Friday morning,Benzinga reports. The firm currently has a $150.00 target price on the stock.

Several other equities analysts also recently commented on ADUS. Wall Street Zen downgraded Addus HomeCare from a "buy" rating to a "hold" rating in a research report on Wednesday, February 26th. Macquarie reaffirmed an "outperform" rating and set a $133.00 target price on shares of Addus HomeCare in a research note on Tuesday, June 10th. Finally, Stephens reiterated an "overweight" rating and issued a $142.00 price target on shares of Addus HomeCare in a report on Wednesday, March 12th. One investment analyst has rated the stock with a hold rating, six have issued a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat.com, Addus HomeCare has a consensus rating of "Buy" and a consensus price target of $142.57.

Addus HomeCare Price Performance

Shares of NASDAQ:ADUS traded down $0.78 during trading on Friday, reaching $113.01. 154,746 shares of the company traded hands, compared to its average volume of 170,573. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.20. Addus HomeCare has a 52 week low of $88.96 and a 52 week high of $136.72. The firm has a market capitalization of $2.08 billion, a PE ratio of 25.51, a PEG ratio of 1.61 and a beta of 0.81. The company's 50 day moving average is $109.13 and its two-hundred day moving average is $111.78.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last announced its quarterly earnings data on Monday, May 5th. The company reported $1.42 earnings per share for the quarter, topping the consensus estimate of $1.33 by $0.09. Addus HomeCare had a return on equity of 9.23% and a net margin of 6.52%. The business had revenue of $337.71 million during the quarter, compared to the consensus estimate of $341.66 million. During the same period in the prior year, the company earned $1.21 EPS. Addus HomeCare's revenue for the quarter was up 20.3% on a year-over-year basis. As a group, sell-side analysts predict that Addus HomeCare will post 4.59 earnings per share for the current year.

Insider Buying and Selling

In related news, EVP Michael D. Wattenbarger sold 2,045 shares of Addus HomeCare stock in a transaction on Tuesday, May 27th. The stock was sold at an average price of $115.00, for a total transaction of $235,175.00. Following the sale, the executive vice president now directly owns 7,796 shares in the company, valued at approximately $896,540. This trade represents a 20.78% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 4.60% of the stock is currently owned by corporate insiders.

Institutional Trading of Addus HomeCare

Several hedge funds have recently made changes to their positions in the company. Capital Research Global Investors purchased a new position in shares of Addus HomeCare in the fourth quarter valued at $51,149,000. American Century Companies Inc. grew its position in Addus HomeCare by 695.8% during the fourth quarter. American Century Companies Inc. now owns 284,346 shares of the company's stock worth $35,643,000 after buying an additional 248,613 shares in the last quarter. Nuveen LLC purchased a new position in shares of Addus HomeCare in the 1st quarter worth about $16,155,000. GAMMA Investing LLC boosted its holdings in shares of Addus HomeCare by 10,307.8% in the 1st quarter. GAMMA Investing LLC now owns 130,930 shares of the company's stock worth $12,948,000 after purchasing an additional 129,672 shares in the last quarter. Finally, Bank of America Corp DE boosted its holdings in shares of Addus HomeCare by 273.6% in the 4th quarter. Bank of America Corp DE now owns 175,070 shares of the company's stock worth $21,945,000 after purchasing an additional 128,211 shares in the last quarter. 95.35% of the stock is currently owned by institutional investors.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.